Low Postseroconversion CD4


Journal

mBio
ISSN: 2150-7511
Titre abrégé: mBio
Pays: United States
ID NLM: 101519231

Informations de publication

Date de publication:
08 01 2019
Historique:
entrez: 10 1 2019
pubmed: 10 1 2019
medline: 11 4 2019
Statut: epublish

Résumé

A positive correlation between virus evolutionary rate and disease progression has been shown for human immunodeficiency virus type 1 (HIV-1) infection. Much less is known about HIV-2, the second causative agent of AIDS. We analyzed 528 HIV-2

Identifiants

pubmed: 30622192
pii: mBio.01245-18
doi: 10.1128/mBio.01245-18
pmc: PMC6325243
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2019 Palm et al.

Références

J Hum Virol. 1998 Nov-Dec;1(7):457-68
pubmed: 10195267
Genetics. 2006 Nov;174(3):1441-53
pubmed: 16951087
Annu Rev Pathol. 2011;6:223-48
pubmed: 21034222
J Virol. 2002 Nov;76(22):11715-20
pubmed: 12388731
Bioinformatics. 2012 Dec 15;28(24):3248-56
pubmed: 23064000
N Engl J Med. 1990 Jan 18;322(3):166-72
pubmed: 1967191
Mol Biol Evol. 1994 Sep;11(5):725-36
pubmed: 7968486
J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Dec 15;16(5):327-32
pubmed: 9420309
AIDS Res Hum Retroviruses. 2002 Nov 1;18(16):1167-73
pubmed: 12487822
AIDS. 2008 Jan 11;22(2):211-5
pubmed: 18097223
MMWR Recomm Rep. 1999 Dec 10;48(RR-13):1-27, 29-31
pubmed: 10632297
Arch Intern Med. 2000 Nov 27;160(21):3286-93
pubmed: 11088091
Mol Biol Evol. 2011 May;28(5):1605-16
pubmed: 21135151
J Mol Evol. 1985;22(2):160-74
pubmed: 3934395
N Engl J Med. 2012 Jul 19;367(3):224-32
pubmed: 22808957
Lancet HIV. 2018 Nov 1;:
pubmed: 30392769
Nat Immunol. 2007 Apr;8(4):329-31
pubmed: 17375091
Virology. 2006 Sep 15;353(1):144-54
pubmed: 16814357
Infect Genet Evol. 2013 Oct;19:369-77
pubmed: 23672855
Blood. 2004 Aug 15;104(4):942-7
pubmed: 15117761
Infect Genet Evol. 2005 Apr;5(3):239-46
pubmed: 15737915
J Infect Dis. 1999 Oct;180(4):1116-21
pubmed: 10479138
Clin Microbiol Rev. 2006 Oct;19(4):728-62
pubmed: 17041142
J Mol Biol. 1987 Aug 5;196(3):641-56
pubmed: 3681970
Rev Med Virol. 2013 Jul;23(4):221-40
pubmed: 23444290
AIDS Res Hum Retroviruses. 2010 Sep;26(9):997-1005
pubmed: 20715931
Syst Biol. 2011 Oct;60(5):685-99
pubmed: 21540409
Infect Dis Rep. 2013 Jun 06;5(Suppl 1):e3
pubmed: 24470967
BMC Evol Biol. 2007 Nov 08;7:214
pubmed: 17996036
J Virol. 2000 Feb;74(3):1554-7
pubmed: 10627569
Mol Biol Evol. 2011 Oct;28(10):2731-9
pubmed: 21546353
AIDS. 2014 Apr 24;28(7):949-57
pubmed: 24812673
Virus Evol. 2016 Sep 06;2(2):vew023
pubmed: 27774306
Retrovirology. 2008 Sep 08;5:78
pubmed: 18778482
PLoS One. 2013 Nov 21;8(11):e80635
pubmed: 24278298
PLoS One. 2013 Jul 23;8(7):e69406
pubmed: 23936006
PLoS One. 2011 Jan 20;6(1):e14548
pubmed: 21283793
J Virol. 1991 Sep;65(9):5073-9
pubmed: 1714524
J Virol. 2015 Nov 25;90(4):2112-8
pubmed: 26608312
AIDS Res Hum Retroviruses. 1995 May;11(5):617-23
pubmed: 7576918
PLoS Comput Biol. 2007 Feb 16;3(2):e29
pubmed: 17305421
Genetics. 2006 Apr;172(4):2665-81
pubmed: 16489234
Nucleic Acids Res. 2015 Jan;43(Database issue):D364-8
pubmed: 25352545
J Clin Microbiol. 2006 Feb;44(2):607-11
pubmed: 16455923
AIDS. 2008 Nov 12;22(17):2257-65
pubmed: 18981765
J Virol. 2017 Oct 27;91(22):
pubmed: 28878089
Science. 2005 Nov 11;310(5750):1025-8
pubmed: 16284180
AIDS. 2009 Jul 31;23(12):1575-82
pubmed: 19521234
J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10 Suppl 2:S67-73
pubmed: 7552516
Retrovirology. 2010 May 19;7:46
pubmed: 20482865
Lancet. 1997 Mar 29;349(9056):911-4
pubmed: 9093252
J Virol. 2010 Jul;84(14):7412-5
pubmed: 20463072
J Infect Dis. 2007 Mar 1;195(5):726-33
pubmed: 17262716
Curr Opin HIV AIDS. 2016 Sep;11(5):537-544
pubmed: 27254747
Bioinformatics. 2005 Mar 1;21(5):676-9
pubmed: 15509596
Nat Rev Genet. 2004 Jan;5(1):52-61
pubmed: 14708016
Syst Biol. 2010 May;59(3):307-21
pubmed: 20525638
J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Aug 1;9(4):422-8
pubmed: 7600111
Mol Biol Evol. 2004 Jul;21(7):1201-13
pubmed: 15014159

Auteurs

Angelica A Palm (AA)

Department of Laboratory Medicine, Lund University, Lund, Sweden.

Philippe Lemey (P)

Department of Microbiology and Immunology, Rega Institute, KU Leuven-University of Leuven, Leuven, Belgium.

Marianne Jansson (M)

Department of Laboratory Medicine, Lund University, Lund, Sweden.

Fredrik Månsson (F)

Department of Translational Medicine, Lund University, Lund, Sweden.

Anders Kvist (A)

Department of Clinical Sciences Lund, Lund University, Lund, Sweden.

Zsófia Szojka (Z)

Department of Biochemistry and Molecular Biology, University of Debrecen, Debrecen, Hungary.

Antonio Biague (A)

National Public Health Laboratory, Bissau, Guinea-Bissau.

Zacarias José da Silva (ZJ)

National Public Health Laboratory, Bissau, Guinea-Bissau.

Sarah L Rowland-Jones (SL)

Nuffield Department of Medicine, NDM Research Building, University of Oxford, Oxford, United Kingdom.

Hans Norrgren (H)

Department of Clinical Sciences Lund, Lund University, Lund, Sweden.

Joakim Esbjörnsson (J)

Department of Laboratory Medicine, Lund University, Lund, Sweden.
Nuffield Department of Medicine, NDM Research Building, University of Oxford, Oxford, United Kingdom.

Patrik Medstrand (P)

Department of Translational Medicine, Lund University, Lund, Sweden patrik.medstrand@med.lu.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH